Lifespot Health Announces to Acquire Seng Vital for Cannabis Opportunities
10/07/18 10:12 PM EDT
Lifespot Health announced that it has completed the acquisition of the remaining 50% of Seng Vital in order to fully own the Seng Vital Company and sm
art cannabis vaporiser assets which includes the Seng-Vital Cannamed Bluetooth cannabis vaporising system, which provides a straightforward, secure and self-controlled method to deliver medicines. The Company updated that for the medical application, the use of an inhaler administration provides users with an easy, safe and self-controlled method to deliver medicines. As reported, vapor market was estimated at $11.43bn in 2016 and is expected to grow $86.43bn by 2025, growing at a CAGR of 23.25% from 2017 to 2025. The Company further updated that the technology can input data from edibles and drinks, opening up global opportunities.